Article info

Download PDFPDF
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Authors

  1. Correspondence to Professor Sudha Sundar, Pan-Birmingham Gynaecological Cancer Centre, Birmingham B152TT, UK; sudha.sundar{at}nhs.net
View Full Text

Citation

Sundar S, Manchanda R, Gourley C, et al
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Publication history

  • Received October 5, 2020
  • Revision received December 6, 2020
  • Accepted December 9, 2020
  • First published January 19, 2021.
Online issue publication 
February 01, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.